Paper36979610
Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers.
Rao Bommi J and 6 others. Biosensors (Basel), 2023. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers. Papers, record 36979610. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979610
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Neoplasms | Major topic |
| Biosensing Techniques | Major topic |
| Male | |
| Humans | |
| Biomarkers, Tumor | |
| Biomarkers |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DST-SERB/RJF/2021/000113 | Department of Science and Technology | PubMed |
Source PubMed
References219
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22820658 | Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results. | Appl Immunohistochem Mol Morphol | 2013 | https://conductscience.org/library/papers/22820658 | PubMed |
| 2 | 28637006 | The effect of CA125 on metastasis of ovarian cancer: old marker new function. | Oncotarget | 2017 | https://conductscience.org/library/papers/28637006 | PubMed |
| 3 | 34234187 | A simple label-free electrochemical sensor for sensitive detection of alpha-fetoprotein based on specific aptamer immobilized platinum nanoparticles/carboxylated-graphene oxide. | Sci Rep | 2021 | https://conductscience.org/library/papers/34234187 | PubMed |
| 4 | 28343975 | Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study. | Lancet Oncol | 2017 | https://conductscience.org/library/papers/28343975 | PubMed |
| 5 | 34736103 | An ultrasensitive carcinoembryonic antigen electrochemical aptasensor based on 3D DNA nanoprobe and Exo III. | Biosens Bioelectron | 2022 | https://conductscience.org/library/papers/34736103 | PubMed |
| 6 | 12928122 | Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC). | Lung Cancer | 2003 | https://conductscience.org/library/papers/12928122 | PubMed |
| 7 | 36531979 | Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study. | Breast J | 2022 | https://conductscience.org/library/papers/36531979 | PubMed |
| 8 | 15317891 | Circulating tumor cells, disease progression, and survival in metastatic breast cancer. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15317891 | PubMed |
| 9 | 20728210 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. | Lancet | 2010 | https://conductscience.org/library/papers/20728210 | PubMed |
| 10 | 11275721 | Assessment of fibrin-fibrinogen degradation products (Accu-Dx) test in bladder cancer patients. | Eur Urol | 2001 | https://conductscience.org/library/papers/11275721 | PubMed |
| 11 | 15591335 | A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15591335 | PubMed |
| 12 | 33044104 | Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection. | Expert Rev Mol Diagn | 2020 | https://conductscience.org/library/papers/33044104 | PubMed |
| 13 | 31803255 | Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors. | Ther Adv Med Oncol | 2019 | https://conductscience.org/library/papers/31803255 | PubMed |
| 14 | 20709523 | Diseases as network perturbations. | Curr Opin Biotechnol | 2010 | https://conductscience.org/library/papers/20709523 | PubMed |
| 15 | 29950525 | Lung cancer stage-shift following a symptom awareness campaign. | Thorax | 2018 | https://conductscience.org/library/papers/29950525 | PubMed |
| 16 | 31088185 | Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer. | Int J Biol Markers | 2019 | https://conductscience.org/library/papers/31088185 | PubMed |
| 17 | 30119234 | Current trends and emerging diagnostic techniques for lung cancer. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/30119234 | PubMed |
| 18 | 7825587 | Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. | Am J Hum Genet | 1995 | https://conductscience.org/library/papers/7825587 | PubMed |
| 19 | 3037205 | Neuron-specific enolase (NSE) as a tumour marker and comparative evaluation with carcinoembryonic antigen (CEA) in small-cell lung cancer. | Med Oncol Tumor Pharmacother | 1987 | https://conductscience.org/library/papers/3037205 | PubMed |
| 20 | 17440939 | Molecular PCA3 diagnostics on prostatic fluid. | Prostate | 2007 | https://conductscience.org/library/papers/17440939 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41459192 | Sensitive immunosensing of melanoma biomarker based on enhanced electrochemiluminescence via electronic metal-support interactions. | Front Chem | 2025 | https://conductscience.org/library/papers/41459192 | PubMed |
| 41326503 | Knowledge attitude and practice regarding cancer screening among Chinese medical students. | Sci Rep | 2025 | https://conductscience.org/library/papers/41326503 | PubMed |
| 40842877 | Circulating long noncoding RNA: New frontiers in biomarker research for mood disorders. | Genom Psychiatry | 2025 | https://conductscience.org/library/papers/40842877 | PubMed |
| 40826140 | Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40826140 | PubMed |
| 40277535 | Microbial Transcription Factor-Based Biosensors: Innovations from Design to Applications in Synthetic Biology. | Biosensors (Basel) | 2025 | https://conductscience.org/library/papers/40277535 | PubMed |
| 39309878 | LINC01094: A key long non-coding RNA in the regulation of cancer progression and therapeutic targets. | Heliyon | 2024 | https://conductscience.org/library/papers/39309878 | PubMed |
| 39066110 | Unveiling Colorectal Cancer Biomarkers: Harnessing Biosensor Technology for Volatile Organic Compound Detection. | Sensors (Basel) | 2024 | https://conductscience.org/library/papers/39066110 | PubMed |
| 38761260 | Artificial intelligence assisted diagnosis of early tc markers and its application. | Discov Oncol | 2024 | https://conductscience.org/library/papers/38761260 | PubMed |
| 38493183 | Redox proteomics of PANC-1 cells reveals the significance of HIF-1 signaling protein oxidation in pancreatic ductal adenocarcinoma pathogenesis. | J Transl Med | 2024 | https://conductscience.org/library/papers/38493183 | PubMed |
| 38362685 | Evolution and Trends of Aptamers in Cancer Research: A Bibliometric Analysis of the Literature over the Last Decade. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/38362685 | PubMed |
| 38007511 | Radiogenomic analysis of cellular tumor-stroma heterogeneity as a prognostic predictor in breast cancer. | J Transl Med | 2023 | https://conductscience.org/library/papers/38007511 | PubMed |
| 37849007 | Colonic medullary carcinoma: an exceedingly rare type of colorectal malignancy: a case report and review of the literature. | J Med Case Rep | 2023 | https://conductscience.org/library/papers/37849007 | PubMed |
| 37730928 | Quantitative measurement of CA 15-3 cancer biomarker using an electrochemical aptasensor based on the electrodeposition of Au thin film on cauliflower-like rGO-MoS2 nanocomposite. | Mikrochim Acta | 2023 | https://conductscience.org/library/papers/37730928 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979610
GET https://conductscience.org/api/papers/v1/36979610/references?page=2